However, in the Prospective Randomized Amlodipine Survival Evaluation PRAISE trial presented at the 44th Annual Scientific Session of the ACC, the administration of amlodipine in patients with heart failure was not accompanied by an adverse effect on morbidity or mortality; rather, the study reported a favorable effect of amlodipine on the survival of patients with nonischemic dilated cardiomyopathy
side effects from doxycycline
